Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Direct oral anticoagulants
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(6)
+
-
Doctoral Thesis
(2)
+
-
Availability
Open access
(5)
+
-
Metadata Only
(3)
+
-
Creation Date
2021
(3)
+
-
2022
(3)
+
-
Faculty
Leiden University Medical Center (LUMC)
(8)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(8)
+
-
Dissertations
(2)
+
-
Topic
Direct oral anticoagulants
(8)
+
-
Atrial fibrillation
(4)
+
-
Stroke
(3)
+
-
Vitamin K antagonists
(3)
+
-
Medication
(2)
+
-
Persistence
(2)
+
-
Show more
Author
Cannegieter, S.C.
(2)
+
-
Chen, Q.G.
(2)
+
-
Huisman, M.V.
(2)
+
-
Lijfering, W.M.
(2)
+
-
Tichelaar, V.Y.I.G.
(2)
+
-
Toorop, M.M.A.
(2)
+
-
Show more
Language
en
(8)
+
-
Search results
(1 - 8 of 8)
show grid
show list
save search
The unique procoagulant adaptations of pseudonaja textilis venom factor V and factor X
Gender differences in antithrombotic treatment in patients with atrial fibrillation from Spain versus the rest of Western Europe
Treatment and outcomes of anticoagulated geriatric trauma patients with traumatic intracranial hemorrhage after falls
Predictors, time course, and outcomes of persistence patterns in oral anticoagulation for non-valvular atrial fibrillation: a Dutch Nationwide Cohort Study
Predictors, time course, and outcomes of persistence patterns in oral anticoagulation for non-valvular atrial fibrillation
Anticoagulation in patients with atrial fibrillation and active cancer
The diagnostic and therapeutic management of pulmonary embolism
Idarucizumab and Factor Xa Reversal Agents: Role in Hospital Guidelines and Protocols